Julie S Downs1, Silva Arslanian2, Wändi Bruine de Bruin1, Valire Carr Copeland3, Willa Doswell3, William Herman4, Kristine Lain5, Joan Mansfield6, Pamela J Murray2, Neil White7, Denise Charron-Prochownik3. 1. Carnegie Mellon University, Pittsburgh, Pennsylvania (Dr Downs, Dr Bruine de Bruin) 2. Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania (Dr Arslanian, Dr Murray) 3. University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Copeland, Dr Doswell, Dr. Charron-Prochownik) 4. University of Michigan Medical Center, Ann Arbor (Dr Herman) 5. University of Kentucky, Lexington (Dr Lain) 6. Joslin Diabetes Clinic Boston, Harvard Medical School, Boston, Massachusetts (Dr Mansfield) 7. St Louis Children’s Hospital, Washington University, St Louis, Missouri (Dr White)
Abstract
PURPOSE: The purpose of this article was to summarize scientific knowledge from an expert panel on reproductive health among adolescents with type 2 diabetes (T2D). METHODS: Using a mental model approach, a panel of experts--representing perspectives on diabetes, adolescents, preconception counseling, and reproductive health--was convened to discuss reproductive health issues for female adolescents with T2D. RESULTS: Several critical issues emerged. Compared with adolescents with type 1 diabetes, (1) adolescents with T2D may perceive their disease as less severe and have less experience managing it, putting them at risk for complications; (2) T2D is more prevalent among African Americans, who may be less trusting of the medical establishment; (3) T2D is associated with obesity, and it is often difficult to change one's lifestyle within family environments practicing sedentary and dietary behaviors leading to obesity; (4) teens with T2D could be more fertile, because obesity is related to earlier puberty; (5) although obese teens with T2D have a higher risk of polycystic ovary syndrome, which is associated with infertility, treatment with metformin can increase fertility; and (6) women with type 2 diabetes are routinely transferred to insulin before or during pregnancy to allow more intensive management. CONCLUSIONS: Findings from the expert panel provide compelling reasons to provide early, developmentally appropriate, culturally sensitive preconception counseling for teens with T2D.
PURPOSE: The purpose of this article was to summarize scientific knowledge from an expert panel on reproductive health among adolescents with type 2 diabetes (T2D). METHODS: Using a mental model approach, a panel of experts--representing perspectives on diabetes, adolescents, preconception counseling, and reproductive health--was convened to discuss reproductive health issues for female adolescents with T2D. RESULTS: Several critical issues emerged. Compared with adolescents with type 1 diabetes, (1) adolescents with T2D may perceive their disease as less severe and have less experience managing it, putting them at risk for complications; (2) T2D is more prevalent among African Americans, who may be less trusting of the medical establishment; (3) T2D is associated with obesity, and it is often difficult to change one's lifestyle within family environments practicing sedentary and dietary behaviors leading to obesity; (4) teens with T2D could be more fertile, because obesity is related to earlier puberty; (5) although obese teens with T2D have a higher risk of polycystic ovary syndrome, which is associated with infertility, treatment with metformin can increase fertility; and (6) women with type 2 diabetes are routinely transferred to insulin before or during pregnancy to allow more intensive management. CONCLUSIONS: Findings from the expert panel provide compelling reasons to provide early, developmentally appropriate, culturally sensitive preconception counseling for teens with T2D.
Authors: Susan M Sereika; Dorothy Becker; Patricia Schmitt; A Blair Powell; Ana Maria Diaz; Andrea F R Fischl; Jennifer Thurheimer-Cacciotti; William H Herman; Denise Charron-Prochownik Journal: Diabetes Care Date: 2016-10-11 Impact factor: 19.112
Authors: Kelly R Moore; Sarah Stotz; Hiba Abujaradeh; Gale Marshall; Martha A Terry; Denise Charron-Prochownik Journal: Int J Gynaecol Obstet Date: 2021-08-19 Impact factor: 3.561
Authors: Denise Charron-Prochownik; Susan M Sereika; Dorothy Becker; Neil H White; Patricia Schmitt; A Blair Powell; Ana Maria Diaz; Jacquelyn Jones; William H Herman; Andrea F Rodgers Fischl; Laura McEwen; Monica DiNardo; Feng Guo; Julie Downs Journal: Diabetes Care Date: 2013-10-15 Impact factor: 19.112
Authors: Eddie Dominguez; Robert Zarnowski; Hiram Sanchez; Antonio S Covelli; William M Westler; Parastoo Azadi; Jeniel Nett; Aaron P Mitchell; David R Andes Journal: mBio Date: 2018-04-03 Impact factor: 7.867